D-0489-2015 Class III Terminated
FDA drug recall D-0489-2015 was initiated by Cardinal Health on Oct 2, 2013 and is designated Class III. Reason for recall: Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with… The recall status is terminated (terminated Sep 30, 2015). Affected quantity: 100 blister cards.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 22, 2015
- Initiation Date
- Oct 2, 2013
- Termination Date
- Sep 30, 2015
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 100 blister cards
Product description
Potassium Chloride, microencapsulated extended-release tablets, 20 mEq, blister card of 30/10 cards in a corrugated shipper, Rx only, Manufactured by Upsher-Smith Laboratories, Inc. Minneapolis, MN 55447 for Sandoz, Inc., Princeton, NJ 08540 Repackaged by Cardinal Health Zanesville, OH 43701
Reason for recall
Labeling: Incorrect or Missing Package Insert: the package insert for the potassium chloride 8 mEq and 10 mEq strength instead of the potassium chloride 10 mEq and 20 mEq strength was packaged with the product.
Distribution pattern
OK
Code information
Lot #: 315004A, Exp 1/15/14; Lot #: 315620A, Exp 1/15/14
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0489-2015
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026